Non-Invasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker
NCT00770458 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000
Last updated 2010-01-06
Summary
Validate that circulating cell free fetal nucleic acid can be used to identify a direct marker for fetal aneuploidy, particularly fetal Down Syndrome (DS), that is better than surrogate markers.
Conditions
- Down Syndrome (Trisomy 21)
- Edwards Syndrome (Trisomy 18)
- Patau Syndrome (Trisomy 13)
- Turner Syndrome
Sponsors & Collaborators
-
Sequenom, Inc.
lead INDUSTRY
Principal Investigators
-
Allan Bombard, MD · Sequenom, Inc.
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-06-30
- Primary Completion
- 2009-10-31
- Completion
- 2009-12-31
Countries
- United States
Study Locations
More Related Trials
-
Development of Non-invasive Prenatal Test for Microdeletion and Other Genetic Syndromes Based on Cell Free DNA
NCT02109770 ·Status: COMPLETED
-
Non-Invasive Determination of Fetal Chromosome Abnormalities
NCT00891852 ·Status: UNKNOWN
-
Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies
NCT02226315 ·Status: TERMINATED
-
Development of a Prenatal Test for Fetal Aneuploidy Detection
NCT01451671 ·Status: COMPLETED
-
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
NCT01852708 ·Status: COMPLETED
-
Biochemical Markers and 2 and 3D Ultrasound to ID Maternal & Fetal Complications
NCT01404221 ·Status: TERMINATED
-
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
NCT01429389 ·Status: RECRUITING
-
Prenatal Test for Fetal Aneuploidy Detection
NCT01256606 ·Status: COMPLETED
-
Automated Screen for Fetal Aneuploidy
NCT03635359 ·Status: UNKNOWN
-
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
NCT01597063 ·Status: COMPLETED
-
Clinical Performance of NIPT in Multiple Gestation Pregnancies
NCT04488393 ·Status: COMPLETED
-
Multiple Gestation Study
NCT02278536 ·Status: COMPLETED
-
Development of a Non-invasive Prenatal Test
NCT01451684 ·Status: COMPLETED
-
Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood
NCT04285814 ·Status: COMPLETED
-
PErsonalized Genomics for Prenatal Abnormalities Screening USing Maternal Blood
NCT03831256 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
First Trimester Risk Assessment Based on Ultrasound and Cell-free DNA vs Combined Screening
NCT04077060 ·Status: COMPLETED ·Phase: NA
-
Prenatal Screening for Down Syndrome With DNAFirst
NCT01966991 ·Status: COMPLETED
-
High Risk Multiple Gestation Study
NCT02278874 ·Status: COMPLETED
-
Comparison of Aneuploidy Risk Evaluations
NCT01663350 ·Status: COMPLETED
-
Prenatal Non-invasive Aneuploidy Test Utilizing SNPs Trial
NCT01545674 ·Status: TERMINATED
-
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
NCT01555346 ·Status: COMPLETED
-
Non-invasive Prenatal Diagnostic Validation Study
NCT01574781 ·Status: COMPLETED
-
Use of a Novel Computerized Decision Aid for Prenatal Aneuploidy Screening
NCT02991729 ·Status: COMPLETED ·Phase: NA
-
Development of an Optimal Approach to Return of Results for Next-generation Sequencing for Prenatal Diagnosis
NCT02255825 ·Status: WITHDRAWN ·Phase: NA
-
Down Syndrome - Comparison of Screening Methods in the 1st and 2nd Trimesters
NCT00006445 ·Status: UNKNOWN ·Phase: NA